|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Cash and due from banks | ||||||||||||||
| Federal funds and other interest-bearing balances | ||||||||||||||
| Total cash and cash equivalents | ||||||||||||||
| Debt securities available-for-sale, at fair value (amortized cost of $316,289 and $237,191 at June 30, 2026 and December 31, 2025) | ||||||||||||||
| Debt securities held-to-maturity, at amortized cost (fair value of $49,054 and $49,308 at June 30, 2026 and December 31, 2025) | ||||||||||||||
| Loans held for sale, at lower of cost or fair value | ||||||||||||||
| Loans held for investment | ||||||||||||||
| Allowance for credit losses on loans | ||||||||||||||
| Loans held for investment, net | ||||||||||||||
| Restricted stock, at cost | ||||||||||||||
| Premises and equipment, net | ||||||||||||||
| Right-of-use asset | ||||||||||||||
| Other real estate owned, net | ||||||||||||||
| Goodwill | ||||||||||||||
| Intangible assets, net | ||||||||||||||
| Bank owned life insurance | ||||||||||||||
| Deferred taxes, net | ||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||
| Total assets | ||||||||||||||
| LIABILITIES | ||||||||||||||
| Noninterest-bearing demand | ||||||||||||||
| Interest-bearing NOW accounts | ||||||||||||||
| Money market and savings accounts | ||||||||||||||
| Time deposits | ||||||||||||||
| Total deposits | ||||||||||||||
| Borrowings | ||||||||||||||
| Operating lease liability | ||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||
| Preferred stock - 50,000,000 shares authorized, no par value; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||
| Common stock - 50,000,000 shares authorized, no par value; issued and outstanding 32,110,117 and 32,418,182 at June 30, 2026 and December 31, 2025 | ||||||||||||||
| Retained earnings | ||||||||||||||
| Accumulated other comprehensive loss - net of taxes | ||||||||||||||
| Total shareholders’ equity | ||||||||||||||
| Total liabilities and shareholders’ equity |
Loading...
